Author

T. Kuosmanen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 2 Ecology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Organism:bacteria (other)· 1 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:ecology & biodiversity· 1 Approach:machine learning (classical)· 1 Assay:metagenomics· 1

Frequent Co-Authors

V. Mustonen· 3 shared J. Cairns· 2 shared D. Kiciatovas· 1 shared F. Borse· 1 shared G. Cabrera-Vives· 1 shared J. Warringer· 1 shared M. Vidal· 1 shared N. Beerenwinkel· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersEvolutionary Biology

V. Mustonen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Quantifying massively parallel microbial growth with spatially mediated interactions

F. Borse, D. Kiciatovas, T. Kuosmanen, M. Vidal, G. Cabrera-Vives, J. Cairns, J. Warringer, V. Mustonen

The paper quantifies microbial growth variability across spatial locations using machine learning and develops a spatial consumer-resource model to explain growth patterns and infer intrinsic growth parameters.

PLOS Computational Biology · Jul 22, 2024Peer-reviewedEcology

Turnover shapes evolution of birth and death rates

T. Kuosmanen, S. Särkkä, V. Mustonen

This paper reformulates population genetics by incorporating turnover rates, showing their evolutionary importance and how they influence fixation, substitution, and demographic transitions.

bioRxiv · Jul 11, 2022Evolutionary Biology

Drug-induced resistance evolution necessitates less aggressive treatment

T. Kuosmanen, J. Cairns, R. Noble, N. Beerenwinkel, T. Mononen, V. Mustonen

This paper shows that aggressive drug treatments can increase resistance evolution by altering mutation rates, and proposes an optimal treatment strategy that minimizes resistance risk.

bioRxiv · Oct 7, 2020Evolutionary Biology